Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Queue
AddedJul 1, 2026
UpdatedJul 1, 2026
Queue

Queue

Seed

Queue builds the world’s first fully autonomous robotic pharmacy.

HQ
Palo Alto, CA, US
Founded
2025
Overview
Compare
Fundraising
Employees
News

Queue is the company building the world’s first fully autonomous robotic pharmacy. Its robotic system takes sealed wholesale medication bottles and outputs filled and verified prescription vials with zero human involvement in the fulfillment process.

The company is headquartered in Palo Alto, California and emerged from stealth in June 2026.

Queue - Products & Services

  • Queue Robotic Pharmacy logo

    Queue Robotic Pharmacy

    The world’s first fully autonomous robotic pharmacy kiosk.

Queue - Similar Companies

Kiyo Robotics logo

Kiyo Robotics

Emancro logo

Emancro

emancro.ai

RobinHealth logo

RobinHealth

Figure logo

Figure

figure.ai

Techmetics Robotics logo

Techmetics Robotics

Shifters logo

Shifters

shiftersai.com

Asteres logo

Asteres

asteres.com

Staq Pharma logo

Staq Pharma

staqpharma.com

greenbox Robotics logo

greenbox Robotics

RoboDock logo

RoboDock

robodock.tech

Ottonomy logo

Ottonomy

ottonomy.io

Qwark logo

Qwark

qwarkhealth.com

Autonomous Healthcare logo

Autonomous Healthcare

Zenith Robotics logo

Zenith Robotics

Rightbot logo

Rightbot

rightbot.com

Queue - Quick Facts

Who are Queue's competitors?

Companies similar to Queue include Kiyo Robotics, Emancro, RobinHealth and Figure.

When was Queue founded?

Queue was founded in 2025.

Where is Queue's headquarters located?

Queue's headquarters is located in Palo Alto, CA, US.

When was Queue's last funding round?

Queue's most recent funding round was for $12.6M (USD) in June 2026.

How much has Queue raised to-date?

As of Jun 30, 2026, Queue has raised a total of $18.6M (USD).

Queue - Classification

Industry
  • Healthcare
Ownership
  • Private
Technology
  • Robotics
Revenue
  • Transactional
Customer
  • Enterprise
Tags
  • Healthtech